| Randomized controlled trial of magnesium sulfate infusion for severe birth asphyxia. | |
| | |
MedLine Citation:
|
PMID: 12225549 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: To determine whether postnatal MgSO(4) infusion (250 mg/kg per day) for 3 days is both safe and able to improve outcome in infants with severe birth asphyxia, as had been suggested by a small pilot study. METHODS: A multicenter randomized controlled trial was conducted. Entry criteria included 5-min Apgar score of seven or less and either failure to initiate spontaneous respiration at 10 min after birth because of asphyxia, or occurrence of clinically apparent seizures within 24 h after birth. Number of subjects was calculated to detect a 50% reduction in incidence of adverse outcomes. RESULTS: Distributions of perinatal factors, neonatal baseline characteristics and severity of hypoxic-ischemic encephalopathy were similar in treated and control groups. No significant differences were observed in duration of clinical seizures, or need for assisted ventilation. Survival with normal results of cranial computed tomography, electroencephalography and establishment of oral feeding by 14 days of age, was significantly more frequent in the treated group than in the control group (12/17 vs 5/16, P = 0.04). No significant differences in blood pressure, heart rate or respiratory rate were observed between groups. CONCLUSION: Postnatal MgSO(4) infusion as above is safe and can improve short-term outcome in infants with severe birth asphyxia. |
| | |
Authors:
|
Hiroyuki Ichiba; Hiroshi Tamai; Hirokuni Negishi; Toru Ueda; Tae-Jang Kim; Yutaka Sumida; Yukihiro Takahashi; Hideshi Fujinaga; Hirotaka Minami; |
Related Documents
:
|
19073329 - Intractable seizures, developmental delay, and the ketogenic diet. 11585329 - Evaluation of the cerebral function monitor as a tool for neurophysiological surveillan... 15188989 - Burst suppression on amplitude-integrated electroencephalogram may be induced by midazo... 18977119 - Risk of major congenital malformations in the offsprings of women with epilepsy is not ... 23105219 - Maple syrup urine disease: an uncommon cause for neonatal metabolic distress. 23644139 - High incidence of partial biotinidase deficiency cases in newborns of greek origin. 7230459 - Birth defects related to bendectin use in pregnancy. i. oral clefts and cardiac defects. 19773099 - Birth after caesarean section: changes over a nine-year period in one australian state. 12169409 - Objects are individuals but stuff doesn't count: perceived rigidity and cohesiveness in... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial |
Journal Detail:
|
Title: Pediatrics international : official journal of the Japan Pediatric Society Volume: 44 ISSN: 1328-8067 ISO Abbreviation: Pediatr Int Publication Date: 2002 Oct |
Date Detail:
|
Created Date: 2002-09-12 Completed Date: 2002-11-20 Revised Date: 2008-05-21 |
Medline Journal Info:
|
Nlm Unique ID: 100886002 Medline TA: Pediatr Int Country: Australia |
Other Details:
|
Languages: eng Pagination: 505-9 Citation Subset: IM |
Affiliation:
|
Department of Pediatrics, Osaka City University Graduate School of Medicine, Osaka, Japan. h-ichiba@med.osaka-cu.ac.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Asphyxia Neonatorum
/
drug therapy* Humans Hypoxia-Ischemia, Brain / prevention & control* Infant, Newborn Magnesium Sulfate / administration & dosage, therapeutic use* Time Factors |
| Chemical | |
Reg. No./Substance:
|
7487-88-9/Magnesium Sulfate |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Different expression of surfactant protein B mature peptide and proprotein at 21 weeks' gestation in...
Next Document: Prevalence of Mycoplasma pneumoniae in children in Diyarbakir, the south-east of Turkey.